Rationale supporting the use of vasoconstrictors for intraperitoneal chemotherapy with platinum derivatives. [electronic resource]
Producer: 20031120Description: 835-48 p. digitalISSN:- 1055-3207
- Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics
- Biological Availability
- Carcinoma -- drug therapy
- Cisplatin -- administration & dosage
- Drug Synergism
- Epinephrine -- administration & dosage
- Female
- Humans
- Infusions, Parenteral
- Male
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Peritoneal Neoplasms -- drug therapy
- Randomized Controlled Trials as Topic
- Risk Assessment
- Sensitivity and Specificity
- Tissue Distribution
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.